fda

St. Jude gets FDA approval for device database
Forbes - NY,USA
AP 05.12.08, 5:01 PM ET Medical device maker St. Jude Medical Inc. said Monday the Food and Drug Administration approved its remote monitoring and data ...
See all stories on this topic

GAO Criticizes FDA Regulatory Letters on Violative DTC Ads
FDA news (subscription) - Falls Church,VA,USA
The FDA continues to be slow in sending warning or untitled letters to pharmaceutical companies that it suspects of violating direct-to-consumer (DTC) ...
See all stories on this topic

FDA Issues Another Heparin Warning, Faces More Backlash in Congress
Newsinferno.com - New York,NY,USA
Some medical facilities still have recalled heparin in their inventories, prompting the Food & Drug Administration (FDA) to issue yet another warning about ...
See all stories on this topic

FDA Approves Amitiza for IBS-C
Pharmaceutical Processing - Rockaway,NJ,USA
The FDA has approved Amitiza (lubiprostone) for the treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in adult women aged 18 and over. ...
See all stories on this topic

FDA approves generic Requip tablets
United Press International - USA
The FDA said it approved Requip (ropinirole hydrochloride) in dosages of 0.25 milligrams, 0.5 milligrams, 1 milligram, 2 milligrams, 3 milligrams and 4 ...
See all stories on this topic

FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment ...
Earthtimes (press release) - London,UK
DAVID'S, Bermuda and COPENHAGEN, Denmark, May 12 -- Warner Chilcott and LEO Pharma announced today that the United States Food and Drug Administration (FDA) ...
See all stories on this topic

FDA OKs new coagulation formulation
United Press International - USA
The FDA said the new formulation of the plasma protein that's essential for the blood-clotting allows the product to be stored at room temperature -- up to ...
See all stories on this topic

ALSO NOTED: FDA OKs Novalar therapy; StemCells files new patent ...
FierceBiotech - Washington,DC,USA
The FDA has OK'd Novalar's OraVerse (phentolamine mesylate) for the reversal of soft-tissue anesthesia and the associated functional deficits resulting from ...
See all stories on this topic

Birth Control Patch – A Threat for Women, FDA Pressed to Remove It
Enews 2.0 - London,England,UK
The FDA has updated the Johnson & Johnson drug's labeling three times to notify about the risks, including once early this year. In the petition to the FDA, ...
See all stories on this topic

Brown rice wins FDA health claim
FoodNavigator-USA - Montpellier,France
By Shane Starling 12-May-2008 - Brown rice has been added to the FDA-approved list of whole grains that may make health claims including reducing the risk ...
See all stories on this topic

Blogs Alert for: fda

Drug Shortage: Digitek (digoxin tablets, USP)
Actavis Totowa (formerly known as Amide Pharmaceutical, Inc.) recalled of all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP). Other manufacturers of digoxin tablets are available and listed on the Drug Shortage ...
FDA Center for Drug Evaluation... - http://www.fda.gov/cder/whatsnew.htm

FDA Advisory Notices: Drugs Linked to Suicidal Thoughts
By Sach Oliver
In just the past few months, the FDA has released several advisory notices to both doctors and the public about drugs linked to suicidal thoughts or actions, including Singulair, epilepsy drugs and the smoking-cessation drug Chantix. ...
Personal Injury Legal News -... - http://www.injuryboard.com/regional-blogs/

Citizen's group petitions FDA to ban bc patch
In 1988, the FDA requested the withdrawal of all oral contraceptives with estrogen levels greater than 50 mcg because of the risk of blood clots and lack of additional contraceptive